Author:
Yonemura Yutaka,Mizumoto Akiyoshi,Ishibashi Haruaki,Takeshita Kazuyoshi,Glehen Oliver,Sugarbaker Paul H.
Reference63 articles.
1. Sugarbaker PH. New standard of care for appendiceal epithelial malignancies and pseudomyxoma peritonei syndrome. Lancet Oncol. 2006;7:69–76.
2. Yonemura Y, Elnemr A, Endou Y, Ishibashi H, Mizumoto A, Miura M, et al. Surgical results of patients with peritoneal carcinomatosis treated with cytoreductive surgery using a new technique named aqua dissection. Gastroenterol Res Pract 2012; Volume 2012, Article ID 521487, 10 pages doi: 10.1155/2012/521487 .
3. Yonemura Y, Canbay E, Endou Y, Ishibashi H, Mizumoto A, Miura M, et al. Peritoneal cancer treatment. Expert Opin Pharmacother. 2014;15:623–36. doi: 10.1517/14656566.2014.879571 .
4. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinoamtosis of colorectal cancer. J Clin Oncol. 2003;21:3737–43.
5. National Institute of Health and Clinical Excellence (NICE). Cytoreduction surgery followed by hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. IPG331. http://www.nice.org.uk/guidance/IPG331 . Accessed 12 Aug 2013.